Advanced Filters
noise

Muscular Dystrophy Clinical Trials

A listing of Muscular Dystrophy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 15,365 clinical trials
T Taina Nykänen, MD, PhD

Intravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal Function

Computer tomography (CT) is the primary imaging option for acute abdominal pain in adults. Intravenous (IV) contrast media is used to improve the CT quality. In patients with impaired renal function, post-contrast acute kidney injury (PC-AKI) has remained a significant concern. Modern retrospective studies have shown no association between worsened …

18 - 100 years of age Both Phase 4
T Tim Darsaut, MD, MSc

International Subarachnoid Aneurysm Trial II

The purpose of this study is to compare the clinical outcome of surgical clipping and endovascular coiling for ruptured intracranial aneurysms not included in the original ISAT Study.

18 - 100 years of age Both Phase N/A
G Gustavo Akerman Augusto, MD

Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

This is a Phase III Randomized Clinical Trial, blind, multicenter, with active controls, to evaluate the immunogenicity and safety of the Quadrivalent Influenza Vaccine (split virion, inactivated) from Instituto Butantan, in two dose scheme (0.25ml and 0.50ml), in infants and children under 3 years of age.

6 - 35 years of age Both Phase 3
D Demetrius Lopes, MD

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke

The study objective is to examine and compare clinical outcomes, as measured by Modified Rankin Scale (mRS) at 90 days (± 15 days) post treatment, and related performance characteristics of the Envi™-SR and concurrent parallel Control Devices currently cleared by the U.S. FDA for treatment of stroke.

18 - 100 years of age Both Phase N/A
L Line S Nissen, MD

Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity

Tonsillectomy, with or without adenoidectomy, in both children and adults is worldwide one of the most commonly performed surgical procedures in otorhinolaryngology, and the number is increasing. Alone in Denmark, approximately 8.000 tonsillectomies are performed annually. Although, tonsillectomy on benign indication is considered to be a minor and frequently performed …

4 - 100 years of age Both Phase N/A
m mohamed G. Zeinhom, MD

Citicoline in Ischemic Stroke, a Randomized Trial

Along with the current clinical trial, the efficacy and safety of a 1000 mg daily citicoline administered within 24 hours of the first-ever ischemic stroke and lasted 12 months compared to placebo were assessed through MoCA, NIHSS, mRS, and possible adverse effects.

18 - 75 years of age Both Phase 3
m mohamed G. Zeinhom, MD

Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever large-vessel ischemic stroke compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.

18 - 75 years of age Both Phase 3
s sherihan R ahmed, MD

Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of ticagrelor administered within 24 hours of the first-ever large-vessel ischemic stroke compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.

18 - 75 years of age Both Phase 3
s sherihan R ahmed, MD

Clopidogrel Versus Cilostazol in Ischemic Stroke

Along with the current clinical trial, the efficacy and safety of a 300 mg loading dose of ticagrelor administered within 24 hours of the first-ever moderate to severe ischemic stroke compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.

18 - 75 years of age Both Phase 3
m mohamed G. Zeinhom, MD

Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction

The investigators evaluated whether the characteristics of ischemic stroke patients, door-to-needle time, and stroke risk factors were predictive variables for different subtypes of post-alteplase hemorrhagic transformation of brain infarction.

18 - 75 years of age Both Phase 4

Rewrite in simple language using AI